Video

Dr Laura Long Says Pathways Are Part of a Bigger Care Delivery Transformation

Historically, people talk about pathways as if they are an answer, but they are really just one component to cancer care delivery, said Laura Long, MD, MPH, president at TheLongView, PC.

Historically, people talk about pathways as if they are an answer, but they are really just one component to cancer care delivery, said Laura Long, MD, MPH, president at TheLongView, PC, and editorial board member for The American Journal of Pharmacy Benefits.

"What [pathways] can do is help reduce variation and help improve the delivery of evidence-based care, but you need to have the rest of the package," she said.

Payment still needs to be aligned with outcomes and the care delivery model needs to become more patient-centered, Dr Long added.

Related Videos
dr mohamad mohty
dr jennifer vidrine
dr ryan jacobs
Video 2 - 3 KOLs are featured in, "Assessing Limitations, Costs, Mobility and Cognition in Progressive Multiple Sclerosis"
Video 1 - 3 KOLs are featured in, "Multiple Sclerosis: Impact, Types, Pathophysiology, and Progression"
dr brian koffman
Justin Oldham, MD, MS, an expert on IPF
Related Content
CH LogoCenter for Biosimilars Logo